James M. Meer's most recent trade in Elanco Animal Health Inc was a trade of 1,161 Common Stock done at an average price of $14.6 . Disclosure was reported to the exchange on July 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Elanco Animal Health Inc | James M. Meer | CHIEF ACCOUNTING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.64 per share. | 03 Jul 2025 | 1,161 | 58,103 (0%) | 0% | 14.6 | 16,997 | Common Stock |
| Elanco Animal Health Inc | James M. Meer | CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 12,158 | 59,264 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | James M. Meer | CHIEF ACCOUNTING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.17 per share. | 01 Mar 2025 | 2,356 | 47,106 (0%) | 0% | 11.2 | 26,317 | Common Stock |
| Elanco Animal Health Inc | James M. Meer | CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 7,825 | 52,153 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | James M. Meer | CHIEF ACCOUNTING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.24 per share. | 19 Feb 2025 | 2,691 | 49,462 (0%) | 0% | 11.2 | 30,247 | Common Stock |
| Elanco Animal Health Inc | James M. Meer | CHIEF ACCOUNTING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.98 per share. | 03 Jan 2025 | 414 | 48,773 (0%) | 0% | 12.0 | 4,960 | Common Stock |
| Elanco Animal Health Inc | James M. Meer | CHIEF ACCOUNTING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.13 per share. | 03 Jul 2024 | 1,160 | 49,187 (0%) | 0% | 14.1 | 16,391 | Common Stock |
| Elanco Animal Health Inc | James M. Meer | CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 9,046 | 52,014 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | James M. Meer | CHIEF ACCOUNTING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.03 per share. | 01 Mar 2024 | 1,667 | 50,347 (0%) | 0% | 16.0 | 26,722 | Common Stock |
| Elanco Animal Health Inc | Meer M. James | CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 2,483 | 43,822 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | James M. Meer | CHIEF ACCOUNTING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.46 per share. | 27 Feb 2024 | 854 | 42,968 (0%) | 0% | 16.5 | 14,057 | Common Stock |
| Elanco Animal Health Inc | Meer M. James | CHIEF ACCOUNTING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.37 per share. | 03 Jan 2024 | 402 | 41,339 (0%) | 0% | 14.4 | 5,777 | Common Stock |
| Elanco Animal Health Inc | James M. Meer | CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 7,977 | 41,741 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | James M. Meer | CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 8,659 | 35,213 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | James M. Meer | CHIEF ACCOUNTING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.01 per share. | 02 Mar 2023 | 1,449 | 33,764 (0%) | 0% | 11.0 | 15,953 | Common Stock |
| Elanco Animal Health Inc | James M. Meer | CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 8,659 | 26,902 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | James M. Meer | CHIEF ACCOUNTING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.26 per share. | 01 Mar 2023 | 673 | 18,243 (0%) | 0% | 11.3 | 7,578 | Common Stock |
| Elanco Animal Health Inc | James M. Meer | CHIEF ACCOUNTING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.01 per share. | 01 Mar 2023 | 348 | 26,554 (0%) | 0% | 11.0 | 3,831 | Common Stock |
| Elanco Animal Health Inc | James M. Meer | CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 3,683 | 18,290 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | James M. Meer | CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 3,540 | 14,607 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | James M. Meer | CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 2,955 | 19,982 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | James M. Meer | CHIEF ACCOUNTING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.98 per share. | 03 Jan 2022 | 1,263 | 17,027 (0%) | 0% | 26.0 | 32,813 | Common Stock |
| Elanco Animal Health Inc | James M. Meer | CHIEF ACCOUNTING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.35 per share. | 03 Jan 2022 | 402 | 18,916 (0%) | 0% | 12.4 | 4,965 | Common Stock |
| Elanco Animal Health Inc | James M. Meer | CHIEF ACCOUNTING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.94 per share. | 03 Jan 2022 | 383 | 19,599 (0%) | 0% | 28.9 | 11,084 | Common Stock |
| Elanco Animal Health Inc | James M. Meer | CHIEF ACCOUNTING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.00 per share. | 03 Jan 2022 | 281 | 19,318 (0%) | 0% | 29 | 8,149 | Common Stock |
| Elanco Animal Health Inc | James M. Meer | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.00 per share. | 03 Jun 2021 | 70 | 11,067 (0%) | 0% | 35 | 2,450 | Common Stock |
| Elanco Animal Health Inc | James M. Meer | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 2,972 | 11,558 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | James M. Meer | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.34 per share. | 01 Mar 2021 | 337 | 11,137 (0%) | 0% | 32.3 | 10,899 | Common Stock |
| Elanco Animal Health Inc | James M. Meer | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.65 per share. | 01 Mar 2021 | 84 | 11,474 (0%) | 0% | 33.7 | 2,827 | Common Stock |
| Elanco Animal Health Inc | James M. Meer | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2021 | 1,950 | 9,257 (0%) | 0% | 0 | Common Stock | |
| Elanco Animal Health Inc | James M. Meer | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.58 per share. | 22 Feb 2021 | 671 | 8,586 (0%) | 0% | 30.6 | 20,519 | Common Stock |
| Elanco Animal Health Inc | James Meer | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.53 per share. | 01 Oct 2020 | 610 | 7,307 (0%) | 0% | 27.5 | 16,793 | Common Stock |